Brief Comments on the Rapid Response (RR) Report from Healthcare Improvement Scotland on the Use of Cytosponge™ for the Detection of Pre-malignant or Early Curable Oesophageal Cancer

Research output: Book/ReportCommissioned report

12 Downloads (Pure)

Abstract

It can be argued that the question of capacity – in particular, the current (and quite possibly prolonged) lack of hospital resources to conduct planned endoscopy procedures in a timely manner – has received insufficient attention in the recent Rapid Response report from HIS. Widespread use of Cytosponge would enable substantially more patients (50% or more depending on COVID-19 and other factors) to be seen in any given period. Although endoscopy plus biopsy appear to have superior sensitivity (although still less than 100%) and specificity than Cytosponge, this advantage can be negated by a lack of effective capacity to perform these resource-intensive procedures in a timely manner. Instead, using Cytosponge for suitable patients would allow them to be seen and diagnosed closer to the originally planned time, leading where necessary to faster treatments with associated gains in quality-adjusted life years. Any (potentially false) negative results from the Cytosponge test could be reconsidered within a reasonable period of time should the patient’s symptoms persist or worsen.
Original languageEnglish
Place of PublicationGlasgow
PublisherUniversity of Strathclyde
Commissioning bodyScottish Goverment
Number of pages4
Publication statusPublished - 30 Dec 2021

Keywords

  • upper gastrointestinal endoscopy
  • Cytosponge™
  • financial decision making
  • health economics
  • healthcare
  • NHS Scotland

Fingerprint

Dive into the research topics of 'Brief Comments on the Rapid Response (RR) Report from Healthcare Improvement Scotland on the Use of Cytosponge™ for the Detection of Pre-malignant or Early Curable Oesophageal Cancer'. Together they form a unique fingerprint.

Cite this